/Investor DB

BlueYard Capital — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

SeeQC Incseeqc.comin𝕏Jul 2020✓ verified

SEEQC develops a digital quantum computing platform that integrates the core functions of a quantum computer—including qubits and classical control logic—onto superconducting cryogenic chips, aiming to scale qubits without added complexity.

Deep TechQuantum ComputingSemiconductorsElmsford, US

Oleg Mukhanov(Founder)inJohn Levy(Founder)inRaja Bal(CFO)inTim Anglim(Executive Officer)Shu-Jen Han(CTO)inMatt Hutchings(CPO)in

Board seatJason Whitmire· per SEC Form D

Co-investorsNordicNinjaEQT VenturesArcTern VenturesBooz Allen VenturesCambium CapitalLG Technology Ventures+4 more

Bit Biobit.bioin𝕏Jun 2020 · $41.5M✓ verified

bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.

BiotechDeep TechHealthtechMedical Devices

Dr Mark Kotter(Founder)Przemek Obloj(CEO)inEmma Pepperell(CEO)inMark Kotter(Founder)

Co-investorsForesite CapitalARCH Venture PartnersDynamk CapitalGood AI CapitalHarmonix FundHAWKTAIL+8 more

Airtmairtm.comSeries A · Dec 2020 · $7M

Airtm operates a dollar-denominated digital wallet and P2P cross-border payments network built on USDC stablecoins.

Dover, US

Ruben Galindo(Executive Officer, Director)Ruben Galindo Payen(Executive Officer, Director)Josh Kliot(Executive Officer, Director)inAnahita Arora(Executive Officer)Laura Seamon(Executive Officer)

Board seatJason Whitmire· per SEC Form D

Co-investorsCircle VenturesCloud Money VenturesCoinbase VenturesIGNIA

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.